Quarterly report · Q2
6951.TEDINET S100S7G5
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥68.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥162.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥64.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥8.3bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥6.9bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥10.2bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥23.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥10.2bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥9.6bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥7.5bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥17.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥7.5bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥7.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥204.8bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥199.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥189.8bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥95.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥97.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥109.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥101.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥92.7bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥31.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥34.3bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥29.2bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.0bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥37.2bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥42.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.7bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥147.16 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.38 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥349.34 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥141.67 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.63 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 53.4% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥2.9bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥17.2bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥17.2bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥7.0bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥7.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥7.4bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥539m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥44.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥44.1bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.7bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥68.7bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥68.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥11.2bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥2.6bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥20.5bn |
| jpcrp040300-q2r_E01905-000Industrial Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥9.3bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥8.5bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥8.5bn |
| jpcrp040300-q2r_E01905-000Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥270m |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥35.8bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥35.8bn |
| jpcrp040300-q2r_E01905-000Scientific And Measurement Instrumentsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥81m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥64.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥64.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥9.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 546
| Item | Context | Value | Unit |
|---|---|---|---|
| Contract liabilities | Prior1YearInstant | 29649000000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 34162000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1869000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 1891000000 | JPY |
| Other cl | Prior1YearInstant | 7778000000 | JPY |
| Other cl | CurrentQuarterInstant | 7953000000 | JPY |
| Current liabilities | Prior1YearInstant | 80907000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 80903000000 | JPY |
| Long term loans payable | Prior1YearInstant | 6527000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 4286000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 16000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 17000000 | JPY |
| Provision for management board incentive plan trust | Prior1YearInstant | 530000000 | JPY |
| Provision for management board incentive plan trust | CurrentQuarterInstant | 554000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 7760000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 7753000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 317000000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 317000000 | JPY |
| Other ncl | Prior1YearInstant | 1325000000 | JPY |
| Other ncl | CurrentQuarterInstant | 1598000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 16477000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 14527000000 | JPY |
| Liabilities | Prior1YearInstant | 97384000000 | JPY |
| Liabilities | CurrentQuarterInstant | 95431000000 | JPY |
| Capital stock | Prior1YearInstant | 21394000000 | JPY |
| Capital stock | CurrentQuarterInstant | 21394000000 | JPY |
| Capital surplus | Prior1YearInstant | 21271000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 21271000000 | JPY |
| Retained earnings | Prior1YearInstant | 55117000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 60792000000 | JPY |
| Treasury stock | Prior1YearInstant | -904000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -846000000 | JPY |
| Shareholders equity | Prior1YearInstant | 96878000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 102610000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 3947000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 4366000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 76000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -353000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 940000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 2681000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 51000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 94000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 5017000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 6788000000 | JPY |
| Net assets | Prior1YearInstant | 101895000000 | JPY |
| Net assets | CurrentQuarterInstant | 109399000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 199280000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 204830000000 | JPY |
| Net sales | Prior1YTDDuration | 64743000000 | JPY |
| Net sales | CurrentYTDDuration | 68718000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |